IlluminOss Medical Raises $28M in Series C Financing

Written by Jaimie Oh | September 28, 2012 | Print  |
IlluminOss Medical, a manufacturer of photodynamic orthopedic implants, has secured a $28 million Series C round of venture capital financing.The minimally invasive IlluminOss Photodynamic Bone Stabilization System is used to treat fractures through a small entry into the bone. A flexible balloon catheter is inserted into the bone, placed across the fracture site, and infused with a proprietary liquid monomer. The monomer then expands the balloon to assist in the alignment of the fractured bone, and surgeons use a visible light source to illuminate it and convert it into a hardened polymer implant.

More Articles on Orthopedic Devices:

Amedica Receives FDA Approval for Interbody Fusion Device

Smith & Nephew Devices Approved For Additional Indications

Alphatec Spine to Acquire Some Assets of Phygen

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months